GLMDVSSLXN• 6 Months (Normalized)
GLMD vs SLXN (Galmed Pharmaceuticals Ltd. vs Silexion Therapeutics Corp)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GLMD Performance $3.63
+596.74%
Galmed Pharmaceuticals Ltd.
Normalized Baseline0.00%
SLXN Performance $0.32
+%
Silexion Therapeutics Corp
Normalized Baseline0.00%
Alpha Spread Margin GLMD LEADS
+596.74 pts
GLMD outperforming by 596.74 percentage points
GLMDSLXN
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GLMD SLXN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(122 dates)
| Date | GLMD Price | GLMD Gain (%) | SLXN Price | SLXN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 28, 2026 | $3.63 | +596.74% | $- | - | |
| Sep 25, 2026 | $3.63 | +596.74% | $- | - | |
| Sep 24, 2026 | $3.62 | +594.82% | $- | - | |
| Sep 23, 2026 | $3.62 | +594.82% | $0.32 | -97.26% | +692.08% |
| Sep 22, 2026 | $- | $0.39 | -96.59% | - | |
| Sep 21, 2026 | $3.50 | +571.79% | $0.54 | -95.27% | +667.06% |
| Sep 18, 2026 | $3.40 | +552.59% | $0.44 | -96.21% | +648.80% |
| Sep 17, 2026 | $3.48 | +567.95% | $0.38 | -96.70% | +664.65% |
| Sep 16, 2026 | $3.41 | +554.51% | $0.34 | -97.04% | +651.55% |
| Sep 15, 2026 | $3.63 | +595.78% | $0.34 | -97.04% | +692.82% |
| Sep 14, 2026 | $3.82 | +633.21% | $0.39 | -96.65% | +729.86% |
| Sep 11, 2026 | $3.84 | +637.04% | $0.36 | -96.90% | +733.94% |
| Sep 10, 2026 | $4.03 | +673.51% | $0.42 | -96.32% | +769.83% |
| Sep 09, 2026 | $4.63 | +788.68% | $0.35 | -96.96% | +885.64% |
| Sep 08, 2026 | $3.83 | +634.17% | $0.35 | -97.00% | +731.17% |
Page 1 of 9